Carevive Systems

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Carevive Systems sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials 1 currently recruiting 8 completed top decile by trial count

Carevive Systems: 10 sponsored US clinical trials, 1 recruiting.

Carevive Systems sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 8 completed. The most-studied condition in this pipeline is Multiple Myeloma, with 2 trials.

Top-decile sponsor footprint

Carevive Systems ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

10 total, page 1 of 1

RECRUITING

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

NCT05974150
ACTIVE NOT RECRUITING NA

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring

NCT05587972
COMPLETED NA

Improving Cancer Outcomes Through Personalized Care Planning and Symptom Management.

NCT04772118
COMPLETED NA

Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia

NCT04158726
COMPLETED NA

Understanding Evidence-Based Practice Patterns in Advanced NSCLC

NCT03107156
COMPLETED NA

Shared Decision Making in Pain Management Planning in Patients With Cancer

NCT03304145
COMPLETED

Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study

NCT03231579
COMPLETED NA

Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care Planning

NCT03161600
COMPLETED NA

Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma

NCT03068637
COMPLETED NA

Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL

NCT04160442

Therapeutic Areas

Multiple Myeloma 2
Breast Cancer 2
Lung Cancer 2
Gastrointestinal Cancer 1
Acute Myelogenous Leukemia 1
Follicular Lymphoma 1
Non-Small Cell Lung Cancer 1
Diffuse Large B Cell Lymphoma 1
Ovarian Cancer 1

What is open in the Carevive Systems pipeline

1 recruiting of 10 indexed (10% open); 8 completed (80%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Multiple Myeloma (2 trials), 8 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Carevive Systems: open-pipeline peers nationwide

Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.

Carevive Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 510152025 0%10%20%30%40% Total trials Recruiting share Carevive SystemsAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron PharmaceuticalsAbiomedAimmune TherapeuticsAltria Client ServicesAlzheimer's Disease Cooperative Study (ADCS)
Carevive Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Carevive Systems sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 trials (± recruiting share)

Sponsors near 10% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Carevive Systems page

10 registered trials is a research-attention snapshot, not an endorsement of Carevive Systems or any single study.

  • 1 of Carevive Systems's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Multiple Myeloma is the condition Carevive Systems studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Myeloma trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Carevive Systems pipeline card: 10 registered trials from official public datasets.Report a data error.